(KWR) Quaker Chemical - Ratings and Ratios

Quaker Chemical Corporation, operating as Quaker Houghton, is a global provider of industrial process fluids, offering a diverse range of formulated specialty chemical products and chemical management services for heavy industrial and manufacturing applications. The companys extensive product portfolio includes metal removal fluids, cleaning fluids, and corrosion inhibitors, among others, catering to various industries such as steel, aluminum, automotive, and aerospace. With a rich history dating back to 1918, Quaker Chemical Corporation is headquartered in Conshohocken, Pennsylvania, and has established itself as a key player in the specialty chemicals sector.

From a market perspective, Quaker Chemical Corporations stock has shown significant price movements, with its current price standing at $119.42. Analyzing the stocks moving averages, we observe that it is currently above its 20-day and 50-day simple moving averages (SMA20: $109.94, SMA50: $106.89), indicating a positive short-term trend. However, the stock remains below its 200-day moving average (SMA200: $138.38), suggesting a longer-term downtrend. The Average True Range (ATR) of 3.89, equivalent to 3.25%, indicates moderate volatility.

Fundamentally, Quaker Chemical Corporation has a market capitalization of $1.904 billion and a price-to-earnings ratio of 20.40, which is slightly higher than the industry average. The forward P/E ratio of 14.51 suggests expected earnings growth. The companys return on equity (RoE) stands at 6.76%, indicating a relatively stable return for shareholders.

Based on the technical and fundamental data, a forecast for Quaker Chemical Corporations stock can be made. Given the current price is above its short-term moving averages but below its long-term average, a potential buying opportunity may arise if the stock can break through the SMA200 resistance level. With a relatively stable RoE and expected earnings growth, the stock may experience an upward trend. However, the high P/E ratio compared to the forward P/E suggests that the stock may be slightly overvalued, and a correction is possible. Therefore, a cautious approach is recommended, with a potential target price range of $130-$150 in the short term, contingent on the stocks ability to break through the SMA200 and maintain its earnings growth trajectory.